SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-293176
Filing Date
2020-11-13
Accepted
2020-11-13 17:05:56
Documents
14
Period of Report
2020-11-12
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d97992d8k.htm   iXBRL 8-K 42461
2 EX-3.1 d97992dex31.htm EX-3.1 22443
  Complete submission text file 0001193125-20-293176.txt   241175

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pfe-20201112.xsd EX-101.SCH 4518
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfe-20201112_def.xml EX-101.DEF 14109
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20201112_lab.xml EX-101.LAB 23430
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20201112_pre.xml EX-101.PRE 15142
7 EXTRACTED XBRL INSTANCE DOCUMENT d97992d8k_htm.xml XML 6446
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 201312431
SIC: 2834 Pharmaceutical Preparations